Fluorescent capture assay for kinase activity employing an anti-phosphotyrosine antibody as both the capture agent and detecting agent
AssigneePharmacopeia Drug Discovery, Inc.
InventorsJ. Fraser Glickman, James Inglese, Bassam Damaj, Maria L. Webb, Jonathan J. Burbaum
Life of this patent
Estimating the term…
Abstract
A method for determining the level of tyrosine kinase activity in a biological sample is disclosed. The method employs an anti-phosphotyrosine antibody as both the capture agent and the detecting agent. The detecting antibody is labeled with a fluorescent label, for instance, Cy5, Cy5.5 or Cy7 or a lanthanide ion, such as europium, as the signal generating entity. The method is particularly well suited to high throughput screening, for example, for compounds which modulate tyrosine kinase activity.
Claims9
A method for screening a substance for the ability to modulate tyrosine kinase activity comprising the steps:
- (a) exposing a portion of a biological sample to said substance;
- (b) determining the level of tyrosine kinase activity in said exposed portion and in an unexposed portion by:
- (1) contacting said portions individually with a solid phase coated with a first anti-phosphotyrosine antibody so that phosphorylated tyrosine-containing molecules in the biological sample are bound by the antibody to the solid phase;
- (2) contacting the phosphorylated tyrosine-containing molecules that are bound by the first anti-phosphotyrosine antibody to the solid phase with a second labeled anti-phosphotyrosine antibody;
- and
- (3) measuring the amount of labeled anti-phosphotyrosine antibody bound to the solid phase, wherein the amount of labeled anti-phosphotyrosine antibody indicates the level of tyrosine kinase activity in the portions;
- and
- (c) comparing the level of tyrosine kinase activity in said exposed portion with the level of tyrosine kinase activity in the unexposed portion, wherein a difference between the levels indicates that the substance has the ability to modulate tyrosine kinase activity.
A method for screening a substance for the ability to modulate tyrosine kinase activity comprising the steps:
- (a) exposing a portion of a cell population to said substance;
- (b) preparing cell fractions from cells of said exposed portion and from an unexposed portion of said cell population;
- and
- (c) determining the level of tyrosine kinase activity in said cell fractions by:
- (1) contacting said cell fractions with a solid phase coated with a first anti-phosphotyrosine antibody so that phosphorylated tyrosine-containing molecules in the cell fractions are bound by the antibody to the solid phase;
- (2) contacting the phosphorylated tyrosine-containing molecules bound by the first anti-phosphotyrosine antibody to the solid phase with a second labeled anti-phosphotyrosine antibody and
- (3) measuring the amount of labeled anti-phosphotyrosine antibody associated with the solid phase;
- and
- (d) comparing the level of tyrosine kinase activity in said exposed portion with the level of tyrosine kinase activity in the unexposed portion.
Dependencies are inferred from the claim text.